Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ZVRA
Stock Latest News
Company Announcements
Zevra Therapeutics Earnings Call Highlights Growth Pivot
14d ago
ZVRA
Premium
The Fly
Zevra Therapeutics price target raised to $25 from $23 at Guggenheim
16d ago
ZVRA
Premium
Ratings
Analyst Reiterates Buy on Zevra, Keeps DCF-Based Price Target Unchanged at $24 Amid Robust Miplyffa Performance and Pipeline Optionality
17d ago
ZVRA
Premium
Ratings
Zevra Therapeutics: Buy Rating Reiterated as MIPLYFFA Execution, Debt-Free Balance Sheet Support Upside with Price Target Maintained at $26
18d ago
ZVRA
Premium
The Fly
Zevra Therapeutics reports Q1 EPS 60c, consensus 8c
18d ago
ZVRA
Premium
Company Announcements
Zevra Therapeutics Earnings Call Signals Profitable Turn
2M ago
ZVRA
Premium
Ratings
Zevra Pharmaceuticals: SDX Monetization, Debt Elimination, and Miplyffa Ramp Support Buy Rating
2M ago
ZVRA
Premium
Market News
3 Best Stocks to Buy Today, 3/16/2026, According to Top Analysts
2M ago
MOLN
SVCO
Premium
Company Announcements
Zevra Sells SDX Portfolio and Resolves Litigation
2M ago
8K
ZVRA
Premium
The Fly
Zevra Therapeutics sells SDX portfolio to Commave for $50M
2M ago
ZVRA
Premium
The Fly
Zevra Therapeutics initiated with a Buy at BTIG
2M ago
ZVRA
Premium
Company Announcements
Zevra Therapeutics Faces Partnership Hurdles That Could Delay Drug Development and Pressure Financing
2M ago
ZVRA
Premium
The Fly
Midday Fly By: HP Enterprise reports Q1 beat, BioNTech announces new company
3M ago
ABM
CNC
Premium
The Fly
Zevra Therapeutics price target raised to $23 from $22 at Guggenheim
3M ago
ZVRA
Premium
Ratings
Zevra Therapeutics: Strong NPC Enrollment Momentum and Undervalued Rare-Disease Pipeline Support Buy Rating and $26 Target
3M ago
ZVRA
Premium
Company Announcements
Zevra Therapeutics Appoints Justin Renz as New CFO
3M ago
8K
ZVRA
Premium
The Fly
Zevra Therapeutics reports Q4 EPS 20c, consensus 5c
3M ago
ZVRA
Premium
The Fly
Zevra Therapeutics Inc options imply 4.6% move in share price post-earnings
3M ago
ZVRA
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 09, 2026
3M ago
DDD
HPE
Premium
Pre-Earnings
Is ZVRA a Buy, Before Earnings?
3M ago
ZVRA
Premium
The Fly
Zevra Therapeutics appoints Renz as Chief Financial Officer
3M ago
ARDX
ZVRA
Premium
Ratings
Reaffirming Buy on Zevra: Durable Miplyffa Efficacy and Annuity-Like NPC Revenue Support $26 Target
4M ago
ZVRA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
